Beyond ordinary. We craft stories that engage
Viatris, a leader in metabolic disorders, is at the forefront of Diabetes care. Their family of DPP-4 inhibitors, Tutecvi (Vildagliptin) and Tutecvi-C (Vildagliptin + Metformin), is among the most prescribed in the Greek market, known for high efficacy and safety. The task at hand was to develop a compelling tagline and visual identiy that would emphasize the efficacy, quality, and reliability of Tutecvi and Tutecvi Combi. The challenge was to stand out in the competitive landscape and reinforce Viatris' leadership in metabolic disorders.
Copyright © 2025 | All Rights Reserved.
